Statistical Considerations in RCC: Biomarker-Based Studies

Editor

9 years ago

Meredith M. Regan, ScD of the Dana-Farber Cancer Institute presents “Statistical Considerations in RCC: Biomarker-Based Studies” at the 14th International Kidney Cancer Symposium.